Q: Amneal Pharmaceuticals spiralled downward in October 2018, and has been essentially flatlining in the $4-$5 range since 2020. In the generic pharma business, one would think this should be doing somewhat better than it is. Any signs of a recovery on this one? Thanks.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
